Russian Biotechs Keen To Establish Alliances

Russian biotechnology companies are eager to forge joint ventures and partnerships with Indian counterparts, according to Russian Biotechnology Society president Raif Vasilov. The society has reported high levels of interest from its 4,000 members in areas including vaccines and clinical trials, in order to help commercialise innovation. BMI believes that Russia's nascent biotherapeutic sector could benefit substantially from interaction with its Indian

To read the full article, please choose one of the following options: